These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9211161)

  • 1. Effect of a commercial disinfectant ('Virkon') on mouse experimental infection by Cryptosporidium parvum.
    Ares-Mazás E; Lorenzo MJ; Casal JA; Fernández da Ponte B; Castro JA; Freire F
    J Hosp Infect; 1997 Jun; 36(2):141-5. PubMed ID: 9211161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of amine-based disinfectant KENO™COX on the infectivity of Cryptosporidium parvum oocysts.
    Naciri M; Mancassola R; Fort G; Danneels B; Verhaeghe J
    Vet Parasitol; 2011 Jun; 179(1-3):43-9. PubMed ID: 21354705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial activity of 'Virkon'.
    Broadley SJ; Furr JR; Jenkins PA; Russell AD
    J Hosp Infect; 1993 Mar; 23(3):189-97. PubMed ID: 8099093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of selected disinfectants against mycobacteria and cryptosporidia.
    Holton J; Nye P; McDonald V
    J Hosp Infect; 1994 Jun; 27(2):105-15. PubMed ID: 7930537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of two commercial disinfectants on the viability and infectivity of Cryptosporidium parvum oocysts.
    Castro-Hermida JA; Pors I; Méndez-Hermida F; Ares-Mazás E; Chartier C
    Vet J; 2006 Mar; 171(2):340-5. PubMed ID: 16490718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ultraviolet disinfection of drinking water on the viability of Cryptosporidium parvum oocysts.
    Lorenzo-Lorenzo MJ; Ares-Mazas ME; Villacorta-Martinez de Maturana I; Duran-Oreiro D
    J Parasitol; 1993 Feb; 79(1):67-70. PubMed ID: 8437060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of two peroxygen-based disinfectants for inactivation of Cryptosporidium parvum oocysts.
    Quilez J; Sanchez-Acedo C; Avendaño C; del Cacho E; Lopez-Bernad F
    Appl Environ Microbiol; 2005 May; 71(5):2479-83. PubMed ID: 15870337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Antimycobacterial activity of 'Virkon'.
    Auchincloss TR
    J Hosp Infect; 1993 Dec; 25(4):301-4. PubMed ID: 7907629
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of salinity, temperature and storage time on mouse experimental infection by Cryptosporidium parvum.
    Freire-Santos F; Oteiza-López AM; Vergara-Castiblanco CA; Ares-Mazás ME
    Vet Parasitol; 1999 Nov; 87(1):1-7. PubMed ID: 10628695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do iodine water purification tablets provide an effective barrier against Cryptosporidium parvum?
    Butkus MA; Starke JA; Bowman DD; Labare M; Fogarty EA; Lucio-Forster A; Barbi J; Jenkins MB; Pavlo M
    Mil Med; 2005 Jan; 170(1):83-6. PubMed ID: 15724860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of activated sludge in removing Cryptosporidium parvum oocysts from sewage.
    Villacorta-Martinez de Maturana I; Ares-Mazás ME; Duran-Oreiro D; Lorenzo-Lorenzo MJ
    Appl Environ Microbiol; 1992 Nov; 58(11):3514-6. PubMed ID: 1482177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaseous disinfection of Cryptosporidium parvum oocysts.
    Fayer R; Graczyk TK; Cranfield MR; Trout JM
    Appl Environ Microbiol; 1996 Oct; 62(10):3908-9. PubMed ID: 8837451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromine and Chlorine Disinfection of
    Coleman CK; Kim J; Bailey ES; Abebe LS; Brown J; Simmons OD; Sobsey MD
    Environ Sci Technol; 2023 Nov; 57(47):18744-18753. PubMed ID: 37220325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of common laboratory disinfectants on the infectivity of Cryptosporidium parvum oocysts in cell culture.
    Weir SC; Pokorny NJ; Carreno RA; Trevors JT; Lee H
    Appl Environ Microbiol; 2002 May; 68(5):2576-9. PubMed ID: 11976138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the mixed-oxidant solution on infectivity of Cryptosporidium parvum oocysts in a neonatal mouse model].
    Sasahara T; Aoki M; Sekiguchi T; Takahashi A; Satoh Y; Kitasato H; Inoue M
    Kansenshogaku Zasshi; 2003 Feb; 77(2):75-82. PubMed ID: 12661082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculocidal activity of a peroxymonosulphate-based disinfectant-detergent (Virkon).
    De Lorenzi S; Finzi G; Mosca B; Salvatorelli G
    J Hosp Infect; 2008 Jan; 68(1):96-7. PubMed ID: 18069085
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of in vitro efficacy of the disinfectant Virkon.
    Gasparini R; Pozzi T; Magnelli R; Fatighenti D; Giotti E; Poliseno G; Pratelli M; Severini R; Bonanni P; De Feo L
    Eur J Epidemiol; 1995 Apr; 11(2):193-7. PubMed ID: 7672075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of cell culture and quantitative PCR (cc-qPCR) to assess disinfectants efficacy on Cryptosporidium oocysts under standardized conditions.
    Shahiduzzaman M; Dyachenko V; Keidel J; Schmäschke R; Daugschies A
    Vet Parasitol; 2010 Jan; 167(1):43-9. PubMed ID: 19850414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of in vitro evaluation of chemical disinfectants for efficacy on Cryptosporidium parvum oocysts.
    Delling C; Lendner M; Müller U; Daugschies A
    Vet Parasitol; 2017 Oct; 245():5-13. PubMed ID: 28969838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.